Alicia Secor
CIK 1584516 · President and CEO · last filed 2025-12-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
7
Total Filings
31
Lifetime Open-Market Net
-$1.09M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZVRA | Director | — | $12.65 | — | $0 | 1 | 2025-12-09 |
| G1 Therapeutics, Inc. (GTHX) Delisted | Director | 0 | $7.15 | $0 | $0 | 5 | 2024-09-18 |
| Orchard Therapeutics plc (ORTX) Delisted | Director | — | $16.70 | — | $0 | 5 | 2024-01-24 |
| GW PHARMACEUTICALS PLC (GWPH) Delisted | Director | 11,844 | $218.96 | $2.59M | -$36.7K | 9 | 2021-03-02 |
| JUNIPER PHARMACEUTICALS INC (JNP) Delisted | President and CEO | 0 | — | — | $28.8K | 6 | 2018-08-15 |
| Larimar Therapeutics, Inc. (ZFGN) Delisted | Chief Commercial Officer | 5,256 | — | — | -$1.08M | 3 | 2016-04-04 |
| SYNAGEVA BIOPHARMA CORP (GEVA) Delisted | SVP, Chief Operating Officer | — | — | — | $0 | 1 | 2013-09-23 |
Recent Filings · Page 2 of 4
31 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-07 | — | Disp (D) | −10,584 | $0 | |
| 2021-03-02 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | +1,884 | -$22.5K | EDGAR |
| 2021-02-25 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-06 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | +2,136 | -$13.8K | EDGAR |
| 2020-06-19 | Orchard Therapeutics plc (ORTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-08 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-04 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Sell (S) | −1,296 | -$10.8K | EDGAR |
| 2020-01-07 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Sell (S) | −1,536 | -$13.1K | EDGAR |
| 2019-04-12 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Sell (S) | −900 | -$12.8K | EDGAR |
| 2019-03-15 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Exer (M) | +3,580 | $5 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.